Nusinersen treatment may improve aerobic capacity in adult SMA patients

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Jun 16 / Springer Healthcare

Nusinersen treatment may improve aerobic capacity in adult SMA patients

Neuroscience Spinal Muscular Atrophy CURE-SMA-2022

Description

Jacqueline Montes discusses the results of a post-hoc analysis demonstrating a significant improvement in aerobic capacity among adult patients with spinal muscular atrophy treated with nusinersen.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.